Bill Text: IL HB4243 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Amends the Illinois Clinical Laboratory and Blood Bank Act. Requires a blood bank to test or have tested donated blood for evidence of any COVID-19 vaccine and any other messenger ribonucleic acid (mRNA) vaccine components, and requires a blood donor to disclose during each blood donor screening process whether the blood donor has received a COVID-19 vaccine or any other mRNA vaccine during the donor's lifetime. Requires blood or blood components to include on their labels a designation that the blood or blood components tested positive for evidence of a COVID-19 vaccine or any other mRNA vaccine component or was drawn from a blood donor who disclosed the donor have received a COVID-19 vaccine or any other mRNA vaccine during the donor's lifetime. Provides that the Department of Public Health must adopt rules to implement the changes made by the amendatory Act.

Spectrum: Partisan Bill (Republican 3-0)

Status: (Failed) 2025-01-07 - Session Sine Die [HB4243 Detail]

Download: Illinois-2023-HB4243-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB4243 Introduced , by Rep. Jed Davis SYNOPSIS AS INTRODUCED:
210 ILCS 25/7-108 from Ch. 111 1/2, par. 627-108
210 ILCS 25/7-110 from Ch. 111 1/2, par. 627-110
210 ILCS 25/7-111 from Ch. 111 1/2, par. 627-111
210 ILCS 25/7-120 new
Amends the Illinois Clinical Laboratory and Blood Bank Act. Requires a blood bank to test or have tested donated blood for evidence of any COVID-19 vaccine and any other messenger ribonucleic acid (mRNA) vaccine components, and requires a blood donor to disclose during each blood donor screening process whether the blood donor has received a COVID-19 vaccine or any other mRNA vaccine during the donor's lifetime. Requires blood or blood components to include on their labels a designation that the blood or blood components tested positive for evidence of a COVID-19 vaccine or any other mRNA vaccine component or was drawn from a blood donor who disclosed the donor have received a COVID-19 vaccine or any other mRNA vaccine during the donor's lifetime. Provides that the Department of Public Health must adopt rules to implement the changes made by the amendatory Act.
LRB103 34691 AWJ 64536 b
A BILL FOR
HB4243 LRB103 34691 AWJ 64536 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Clinical Laboratory and Blood Bank
Act is amended by changing Sections 7-108, 7-110, and 7-111
and by adding Section 7-120 as follows:
(210 ILCS 25/7-108) (from Ch. 111 1/2, par. 627-108)
Sec. 7-108. Duties of blood banks. A blood bank shall:
(a) Collect, process, and provide for use blood or blood
components from a blood donor only upon the consent of that
donor and under the direction or delegated direction of the
blood bank Medical Director.
(b) Transfuse blood or blood components upon the request
of a physician licensed to practice medicine in all its
branches, a dentist, or a podiatric physician who is on the
medical staff of a hospital and has permission from the
medical staff to make such a request. If the request is oral,
the physician or other authorized person shall submit a
written request to the blood bank within 48 hours. If the blood
bank does not receive the written request within that period,
it shall note that fact in its records.
(c) Test or have tested donated blood for evidence of any
COVID-19 vaccine or any other messenger ribonucleic acid

HB4243 - 2 - LRB103 34691 AWJ 64536 b
(mRNA) vaccine components, including evidence of lipid
nanoparticles and spike protein from a vaccine.
(d) Require a blood donor to disclose, during each blood
donor screening process, whether the blood donor has received
a COVID-19 vaccine or any other mRNA vaccine during the
donor's lifetime.
(Source: P.A. 98-214, eff. 8-9-13.)
(210 ILCS 25/7-110) (from Ch. 111 1/2, par. 627-110)
Sec. 7-110. Blood labeling. Every person who withdraws
blood from an individual or separates blood into components by
physical processes shall affix to each container of blood or
blood components a label that includes (1) the appropriate
donor classification, "volunteer donor" or "paid donor", in no
less prominence than the word "blood" or the name of the blood
component and (2) a designation, if true, that the blood
tested positive for evidence of a COVID-19 vaccine or any
other messenger ribonucleic acid (mRNA) vaccine or was drawn
from a blood donor who disclosed that the donor has received a
COVID-19 vaccine or any other mRNA vaccine during the donor's
lifetime.
Any person who receives blood or blood components in this
State from a federally licensed blood bank in another state
shall not be required to relabel a container of blood or blood
components if the container of blood or blood components is
labeled with the appropriate donor classification, "volunteer

HB4243 - 3 - LRB103 34691 AWJ 64536 b
donor" or "paid donor", in no less prominence than the word
"blood" or the name of the blood component.
(Source: P.A. 87-1269.)
(210 ILCS 25/7-111) (from Ch. 111 1/2, par. 627-111)
Sec. 7-111. Administration of labeled blood. No person may
administer blood by transfusion in this State or transfer or
offer to transfer blood for transfusion purposes by any type
of transaction unless the container of the blood is labeled as
required by Section 7-110 and, if the container is designated
under item (2) of Section 7-110, an acknowledgment from the
person receiving the transfusion, or the authorized
representative of the person, that the person or
representative has been given the opportunity to refuse blood
designated under item (2) of Section 7-110.
When blood is administered by transfusion in this State,
the identification number of the unit of blood shall be
recorded in the patient's medical record and the label on the
container of the blood shall not be removed before or during
the administration of that blood by transfusion.
(Source: P.A. 87-1269.)
(210 ILCS 25/7-120 new)
Sec. 7-120. Messenger ribonucleic acid (mRNA) vaccine
testing and labeling; rules. The Department must adopt rules
to implement the changes made by this amendatory Act of the

HB4243 - 4 - LRB103 34691 AWJ 64536 b